1. Home
  2. CACC vs GKOS Comparison

CACC vs GKOS Comparison

Compare CACC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

HOLD

Current Price

$463.42

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$115.92

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACC
GKOS
Founded
1972
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.4B
IPO Year
1992
2015

Fundamental Metrics

Financial Performance
Metric
CACC
GKOS
Price
$463.42
$115.92
Analyst Decision
Sell
Strong Buy
Analyst Count
2
13
Target Price
$465.00
$125.54
AVG Volume (30 Days)
104.4K
865.8K
Earning Date
01-29-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
151.44
N/A
EPS
37.89
N/A
Revenue
$1,232,900,000.00
$469,820,000.00
Revenue This Year
$129.15
$31.15
Revenue Next Year
$1.97
$24.15
P/E Ratio
$12.21
N/A
Revenue Growth
45.72
30.38
52 Week Low
$401.90
$73.16
52 Week High
$560.00
$163.71

Technical Indicators

Market Signals
Indicator
CACC
GKOS
Relative Strength Index (RSI) 52.38 76.42
Support Level $454.14 $105.88
Resistance Level $485.00 $116.72
Average True Range (ATR) 14.70 3.26
MACD 0.09 0.07
Stochastic Oscillator 39.55 94.61

Price Performance

Historical Comparison
CACC
GKOS

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: